律师事务所调查ADMA Biologic公司在审计员意外辞职和股票下跌后可能违反证券规定的行为。 Law firms investigate ADMA Biologics for potential securities violations following unexpected auditor resignation and stock decline.

Bragar Eagel & Squire, P.C., 布拉加尔·伊格尔 & Squire, P.C. Bragar Eagel & Squire, P.C. Bleichmar Fonti & Auld LLP正在调查ADMA Biologics公司在公司审计员CohnReznick LLP于2024年10月9日意外辞职后可能违反联邦证券法的行为。 and Bleichmar Fonti & Auld LLP are investigating ADMA Biologics, Inc. for potential violations of federal securities laws after the unexpected resignation of the company's auditor, CohnReznick LLP, on October 9, 2024. 这一事件导致股票价值明显下降。 This event caused a notable decline in stock value. 这两家律师事务所正就潜在的法律索赔和代理选择向受影响的股东伸出援手。 Both law firms are reaching out to affected shareholders for potential legal claims and representation options.